Opleidingen details Merck B.V.
Medical Update on current & future Multiple sclerosis treatments (ID nummer: 278423)
Cursus afgewezen!
Nascholing met (fysieke) bijeenkomst(en)/ accreditatie per bijeenkomst
Deze cursus is (nog) niet geaccrediteerd. De cursus kan om die reden niet aan dossiers worden toegevoegd.

AIM OF MEETING

This highly interactive live, educational meeting will provide attendees with the most recent information about new and emerging treatment strategies for patients with multiple sclerosis (MS) and how to best incorporate this information into their clinical practice. Through the use of interactive presentations and small group discussions, attendees will be able to personalize the education in order to have the most benefit to their ability to manage patients with MS.

Topics include:

1. Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS: HCP and Patient Viewpoints

2. Therapeutic MOAs in MS: Targeting T- and B-cells to reset the immune system, including immunosuppression

3. Simplifying the MS Patient’s Journey

(Mini)symposium
Bestand  
Pre Biemond flyer 15032017.pdf24-1-2017 14:16132 KB
0
Hoofdniveau
Multipele Sclerose
15-3-2017
Tijd18:30 - 22:00
LocatieNoordwijkerhout (NL) (Toon kaart)

14-12-2016
Tijd18:30 - 22:00
LocatieVeldhoven (NL) (Toon kaart)

 Farmaceutisch bedrijf

Tupolevlaan 41-61
1119NW
Schiphol Rijk
020-6582813